Navigation Links
Cleveland Clinic Unveils Top 10 Medical Innovations for 2012
Date:10/6/2011

een engineered to help restore function. Now comes the computerized bionic leg with its microprocessors and computer chips that can rival the functionality provided by biological limbs.

6. Implantable Device to Treat Complex Brain Aneurysms – A new minimally-invasive procedure can safely and effectively treat brain aneurysms without open surgery by implanting an FDA-approved device directly into the artery. Consisting of a flexible braided mesh tube made of platinum and nickel-cobalt chromium alloy, this device can be delivered by catheter and used to block off large, giant, or wide-necked aneurysms in the damaged internal carotid artery.

5. Increasing Discovery with Next-Generation Gene Sequencing – The best way to get to the root cause of serious illness is to sequence a person's genome. Leading geneticists envision a day soon when everyone's genome will be sequenced and included as a routine part of their medical records. Next-generation sequencing machines can help achieve this goal in the near future with the wider dissemination of faster and affordable sequencing machines.

4. Medical Apps for Mobile Devices – Medical apps have several significant advantages: reliable medical information is always up to date, doctors can answer patient queries quickly by accessing data without ever leaving the patient's bedside, and many medical apps also have interactive features that help doctors choose appropriate screening tests for patients and calculate a patient's risk of developing a host of diseases.

3. Concussion Management System for Athletes – Head injuries are now such a major medical concern in sports that special patient management tools have been developed. Used by athletes, they instantly detect brain injuries at the moment of contact, and provide patient-specific guidance about when athletes can return to play without risk of further harm. The novel Concussion Management S
'/>"/>

SOURCE Cleveland Clinic
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
2. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
3. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
4. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
5. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
6. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
7. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
8. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
9. CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
10. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
11. Cleveland Clinic Surgeons Perform Nations First Near-Total Face Transplant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ... in two healthcare conferences during the third quarter, the ... Stanley Global Healthcare 2014 Conference.  Alexza,s corporate presentation will ... details on each event are below: , ... 2014 in Boston , MA.  The ...
(Date:7/29/2014)... -- Edwards Lifesciences Corporation (NYSE: EW ), the ... monitoring, today reported net income for the quarter ended June ... and non-GAAP net income of $94.0 million, or $0.88 per ... earlier was $93.3 million, or $0.81 per diluted share, and ... share.  Net sales for the quarter ended ...
(Date:7/29/2014)... -- New high priced hepatitis C drugs will increase ... $2.9 to $5.8 billion next year, according to a ... by the Pharmaceutical Care Management Association (PCMA). Milliman projects ... much as 8.6 percent in 2015 as a result ... The study finds that the majority of ...
Breaking Medicine Technology:Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 2Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 3Edwards Lifesciences Reports Strong Second Quarter Results 2Edwards Lifesciences Reports Strong Second Quarter Results 3Edwards Lifesciences Reports Strong Second Quarter Results 4Edwards Lifesciences Reports Strong Second Quarter Results 5Edwards Lifesciences Reports Strong Second Quarter Results 6Edwards Lifesciences Reports Strong Second Quarter Results 7Edwards Lifesciences Reports Strong Second Quarter Results 8Edwards Lifesciences Reports Strong Second Quarter Results 9Edwards Lifesciences Reports Strong Second Quarter Results 10Edwards Lifesciences Reports Strong Second Quarter Results 11Edwards Lifesciences Reports Strong Second Quarter Results 12Edwards Lifesciences Reports Strong Second Quarter Results 13Edwards Lifesciences Reports Strong Second Quarter Results 14Edwards Lifesciences Reports Strong Second Quarter Results 15Edwards Lifesciences Reports Strong Second Quarter Results 16Edwards Lifesciences Reports Strong Second Quarter Results 17Edwards Lifesciences Reports Strong Second Quarter Results 18Edwards Lifesciences Reports Strong Second Quarter Results 19Edwards Lifesciences Reports Strong Second Quarter Results 20Edwards Lifesciences Reports Strong Second Quarter Results 21Edwards Lifesciences Reports Strong Second Quarter Results 22Edwards Lifesciences Reports Strong Second Quarter Results 23Edwards Lifesciences Reports Strong Second Quarter Results 24Edwards Lifesciences Reports Strong Second Quarter Results 25New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2
(Date:7/30/2014)... Bridgeport, Connecticut (PRWEB) July 30, 2014 ... released a new magnetic sports bracelet for pain relief ... 100 times strength carbonized titanium embedded in a silicone ... titanium. It also has Germanium and is embedded with ... magnetic balance bracelet. , “Pain Free Living has 12 ...
(Date:7/29/2014)... 30, 2014 VisitandCare.com today ... been added to the company’s exclusive network to help ... of joint efforts — as top fertility clinics in ... offer affordable, state-of-the-art, and successful IVF treatments. , The ... a comprehensive study by professionals at VisitandCare.com. The goal ...
(Date:7/29/2014)... MO (PRWEB) July 30, 2014 ... have recently been awarded the Patient-Centered Medical Home ... the National Committee for Quality Assurance. Only one ... NCQA Level I, Level 2, or Level 3 ... participate in Patient-Centered Medical Home report faster access ...
(Date:7/29/2014)... Dignity Sciences Limited, a privately held biopharmaceutical ... I trial with DS107G, an oral formulation of Dihomo ... randomized, placebo-controlled, double-blind, single-ascending and multiple dose Phase I ... of food on DS107G in healthy subjects. , ... following both single and multiple oral doses over 28 ...
(Date:7/29/2014)... July 29, 2014 Daily Gossip indicates ... as all other disturbing symptoms that hemorrhoids commonly causes. ... researcher and natural medicine expert. , The author ... to the elimination of symptoms such as itching, burning, ... Learn more about the H Miracle by visiting the ...
Breaking Medicine News(10 mins):Health News:Superior Magnetics Released New Magnetic Sports Bracelet for Pain 2Health News:Top European Fertility Clinics Join VisitandCare.com 2Health News:Top European Fertility Clinics Join VisitandCare.com 3Health News:Top European Fertility Clinics Join VisitandCare.com 4Health News:Saint Luke’s Medical Group Awarded Patient-Centered Medical Home 2011 Level 3 Recognition 2Health News:DS107G-01 – Successful Completion of Phase I Oral DGLA Clinical Trial 2Health News:H Miracle Review Exposes Natural Method to Cure Hemorrhoids 2
... for growth hormone therapy’s anti-aging powers – says a team ... papers based on growth hormone.// ,'There is certainly ... to an otherwise healthy person will make him or her ... potential for adverse side effects.' - says Dr. Hau Liu, ...
... a member of a large family may not be best ... greatly influenced the development of stomach cancer linked to the ... to be especially vulnerable to the most common type of ... the records of more than 7,000 Japanese-American men who were ...
... have reported an interesting find: statins, or drugs used ... actually have an added benefit; //reduce the chance of ... Australians use pop statins, which are lipid-modifying drugs that ... drug for reducing cholesterol levels. , The drug ...
... ideal world, the answer is no, as breast milk ... ,However, in the same developing countries where the ... is often considered the only safe and nutritious food ... research is needed. ,A new study conducted ...
... true; for fat people and inventors. ,Scientists have always ... Britain are no exception. //Currently, two thirds of the population can ... to put a morbidly obese figure of 2.2 million pounds ... London. ,Bloom’s quest is to create a chewing gum or ...
... chicken eggs that can be used to produce drugs like those ... at Edinburgh, Scotland have claimed to create a flock ... to create life saving drugs. ,These drugs could ... National Health Service incurs, according to them. , For ...
Cached Medicine News:Health News:Is Growth Hormone – a Key to Longevity 2Health News:Link Between Family Size and Stomach Cancer Found 2Health News:Link Between Family Size and Stomach Cancer Found 3Health News:Chew That Fat Away 2Health News:No Pills Just Omelets 2
... The Vasotrax is an ... pressure and heart rate non-invasively, ... fact, significantly more accurate than ... On a full battery charge, ...
... Inhibins are heterodimeric proteins that suppress the ... the pituitary. Inhibin consists of two distinct ... together. Inhibin A consists of the alpha-subunit ... alpha-subunit and betaB-subunit. Only the dimeric forms ...
... II (IGF-II) is a 7.5 kDa peptide which ... postulated to have mitogenic and metabolic actions involved ... mediated by binding to target cell receptors. IGF-II ... IGF receptor, a monomeric protein which also serves ...
... A (PAPP-A) is a large placenta-derived ... high concentrations by placental trophoblast cells, ... circulation in increasing concentrations throughout gestation ... specific to pregnancy since measurable levels ...
Medicine Products: